-+ 0.00%
-+ 0.00%
-+ 0.00%

Shaily Engineering Plastics And 2 Indian Growth Stocks To Watch

Simply Wall St·10/11/2026 10:31:42
Listen to the news

Indian growth stocks are drawing extra attention after Elon Musk promised that Starlink would be priced affordably in India, just as Reliance Jio lines up a record IPO. Investor focus is snapping back to businesses that can grow earnings quickly while still keeping their finances in check. This article walks through three high growth Indian companies from a quality focused screener that fit that bill.

The three stocks below are only a small sample. The full screen surfaces 142 more Indian growth stories that share similar earnings potential and balance sheet quality but are not covered here.

If you want to identify and analyze the ideas that best fit your own risk profile and time horizon, head straight to the Healthy high growth potential screener.

Shaily Engineering Plastics (BSE:501423)

Shaily Engineering Plastics combines contract manufacturing for complex drug delivery devices with a broader plastics portfolio, giving the Healthy high growth potential theme direct exposure to pharma demand while keeping a diversified base across household, personal care and industrial products.

Shaily Engineering Plastics generates about ₹10.25b in revenue from customised plastic and other material components and has a market value of roughly ₹140.91b.

"Although the GLP-1 opportunity is expanding rapidly worldwide and Shaily has onboarded a large roster of generic players across multiple countries, delays in regulatory approvals or slower than expected generic capture from innovators could cap utilization of its expanded pen capacity and temper healthcare revenue growth."

The real swing factor for Shaily Engineering Plastics is how one concentrated therapy cycle shapes demand, pricing power and ultimately earnings quality.

If that therapy cycle is what catches your eye, read the full narrative for Shaily Engineering Plastics to see how capacity, customer mix and pricing power could be accelerating beneath the surface.

BSE:501423 Earnings & Revenue Growth as at Oct 2026
BSE:501423 Earnings & Revenue Growth as at Oct 2026

Timex Group India (BSE:500414)

Timex Group India runs a branded watch business across Timex and licensed premium labels, with earnings in the Healthy high growth potential theme tied mainly to this consumer segment. It generated about ₹8.49b from manufacturing and trading watches and related services, and has a market value near ₹73.22b.

Timex Group India pairs branded watches and licensed luxury labels with multi channel distribution, and analysts expect earnings to grow strongly over the next 3 years from this core category. Investors get improving profitability and high growth forecasts, with the real test being how pressure on future pricing aligns with those expectations.

That pricing pressure question is exactly why a fresh look at the 2 key rewards and 1 important warning sign can show where Timex Group India earnings expectations might be stretching or still conservative.

BSE:500414 Earnings & Revenue Growth as at Oct 2026
BSE:500414 Earnings & Revenue Growth as at Oct 2026

Cemindia Projects (BSE:509496)

Cemindia Projects is a construction contractor focused on large marine and heavy civil works, with earnings tied closely to multi year infrastructure projects that fit the Healthy high growth potential theme. It generated about ₹102.05b from construction and has a market value near ₹193.50b.

Cemindia Projects matters in this screener because its concrete intensive port, metro and foundation projects can lock in earnings visibility over several years when the order pipeline is strong.

"The company's large and growing order book, supported by its ability to secure large-ticket jobs across metro, marine, ports, and airport infrastructure, positions it to benefit from India's accelerating pace of urbanization and expansion in infrastructure spending, likely driving multi-year revenue growth."

What happens to that growth story if one unseen pressure on funding costs and project cash flows starts to bite harder?

When funding costs and cash flow timing start to bite, the full narrative for Cemindia Projects shows how Cemindia Projects could still convert its heavy order book into accelerating value.

BSE:509496 Earnings & Revenue Growth as at Oct 2026
BSE:509496 Earnings & Revenue Growth as at Oct 2026

Seeking Fresh Alternatives Beyond Today

Fresh breakouts and under the radar momentum can move fast, and the best entries rarely stay open for long. Scan these curated ideas before the crowd and consider acting while they are still available.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.